Product Information

ANASTROZOLE 1 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.1485 per EA under NDC 68382020906. Its NADAC has been published 677 times since Nov 28, 2013.

FDA first approved this application on Jun 28, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The Low Outlier badge above means this manufacturer's average price in the Anastrozole market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

ANASTROZOLE 1 MG TABLET

Anastrozole
$0.1485per EA
Low Outlier

Strength

1 mg/1

NDC

68382020906

Classification

Generic

Dosage Form

TABLET, COATED

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

ANASTROZOLE

Approval Type

Generic (ANDA)

FDA Application

ANDA078921

FDA Approved

6/28/2010

TE Code

AB

On Market Since

6/27/2010

Pharmacological Classes

Aromatase Inhibitor
Aromatase Inhibitors

Price Statistics

The NADAC for ANASTROZOLE 1 MG TABLET has been published 677 times since Nov 28, 2013, and over the history we have for it it has declined 22.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1485 per EA
All-time high$0.2119 (Mar 12, 2014)
All-time low$0.1041 (Jul 20, 2022)
52-week high$0.1485
52-week low$0.1355
Median price$0.1410
Average price$0.1454
Largest weekly change+32.1% (Aug 21, 2024)
Weeks tracked677
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

+4.9%

3M

+9.6%

6M

+7.5%

1Y

+6.3%

3Y

-6.0%

5Y

+11.8%

All

-22.8%

Generic Alternatives

The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ANASTROZOLE 1 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ANASTROZOLE 1 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.1485 per EA (NDC 68382020906), effective Nov 11, 2026.

How has the price of ANASTROZOLE 1 MG TABLET changed over time?

Over the history we have for it, the NADAC for ANASTROZOLE 1 MG TABLET has declined 22.8%. It has been tracked across 677 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for ANASTROZOLE 1 MG TABLET?

Since Nov 28, 2013, the NADAC for ANASTROZOLE 1 MG TABLET has ranged from a low of $0.1041 (Jul 20, 2022) to a high of $0.2119 (Mar 12, 2014), with a median of $0.1410 per EA.

Are there cheaper alternatives to ANASTROZOLE 1 MG TABLET?

Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ANASTROZOLE 1 MG TABLET, is $0.1366 per EA — about 8% below ANASTROZOLE 1 MG TABLET.

Who manufactures ANASTROZOLE 1 MG TABLET?

ANASTROZOLE 1 MG TABLET (NDC 68382020906) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.